Senores Pharma.

{
  "main_header": {
    "sid": 10039497,
    "name": "Senores Pharma.",
    "stock_name": "Senores Pharma.",
    "full_name": "Senores Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/senores-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "783.00",
    "chg": 51.8,
    "chgp": "7.08%",
    "dir": 1,
    "prev_price": "731.20",
    "mcapval": "3,606.00 Cr",
    "mcap": "Small Cap",
    "scripcode": "544319",
    "symbol": "SENORES",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE0RB801010",
    "curr_date": "Mar 25",
    "curr_time": "",
    "bse_nse_vol": "4.08 lacs",
    "exc_status": "Active",
    "traded_date": "Mar 25, 2026",
    "traded_date_str": "2026 03 25",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/senores-pharma-10039497-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Senores Pharmaceuticals Ltd Surges 7.65% to Day's High of Rs 787.15 — Outperforms Sector by 6 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-hits-intraday-high-with-765-surge-on-25-mar-2026-3916003",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SenoresPharmace_priceRelatedfactors_3916003.png",
        "date": "2026-03-25 10:21:36",
        "description": "The Sensex climbed 1.67% on 25 Mar 2026, yet Senores Pharmaceuticals Ltd outpaced the broader market with a 7.65% gain, reaching an intraday high of Rs 787.15. This 6-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a market-wide lift."
      },
      {
        "title": "Senores Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/senores-pharmaceuticals-ltd-is-rated-hold-3898624",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SenoresPharmace_mojoScore_3898624.png",
        "date": "2026-03-18 10:10:03",
        "description": "Senores Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 06 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and overall market standing."
      },
      {
        "title": "Senores Pharmaceuticals Ltd Technical Momentum Shifts Signal Stabilisation Amid Mixed Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-technical-momentum-shifts-signal-stabilisation-amid-mixed-indicators-3895801",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SenoresPharmace_technicaldot_3895801.png",
        "date": "2026-03-17 08:04:37",
        "description": "Senores Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of technical indicators. Despite recent price gains, the stock’s mixed signals across MACD, RSI, moving averages, and volume-based metrics suggest cautious optimism for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Senores Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/senores-pharmaceuticals-ltd-is-rated-hold-3877839",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SenoresPharmace_mojoScore_3877839.png",
        "date": "2026-03-07 10:10:27",
        "description": "Senores Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 06 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 March 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Senores Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicators-3868454",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SenoresPharmace_technicaldot_3868454.png",
        "date": "2026-03-04 08:08:18",
        "description": "Senores Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bearish stance. Despite a modest daily price decline, the stock’s technical indicators present a complex picture, with some signals suggesting caution while others hint at potential resilience in the near term."
      },
      {
        "title": "Senores Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/senores-pharmaceuticals-ltd-is-rated-hold-3852826",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SenoresPharmace_mojoScore_3852826.png",
        "date": "2026-02-24 10:10:04",
        "description": "Senores Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 06 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Senores Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/senores-pharmaceuticals-ltd-is-rated-hold-3834972",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SenoresPharmace_mojoScore_3834972.png",
        "date": "2026-02-12 10:10:03",
        "description": "Senores Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 06 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 12 February 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Senores Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/senores-pharmaceuticals-ltd-is-rated-hold-3814203",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SenoresPharmace_mojoScore_3814203.png",
        "date": "2026-02-01 10:10:04",
        "description": "Senores Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 06 November 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 01 February 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Senores Pharmaceuticals Gains 1.40%: 4 Key Factors Driving the Week’s Moves",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-gains-140-4-key-factors-driving-the-weeks-moves-3802809",
        "imagepath": "",
        "date": "2026-01-24 09:00:07",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Jan 19:</strong> Stock opens strong at Rs.806.55 (+2.06%) despite Sensex decline</p>\n                    <p><strong>Jan 20:</strong> Q3 FY26 results reveal robust growth but stock dips 2.90%</p>\n                    <p><strong>Jan 21:</strong> Intraday high of Rs.838.60 with 7.13% surge on strong financial trend</p>\n                    <p><strong>Jan 22:</strong> Quality grade upgraded amid strong fundamentals</p>\n                    <p><strong>Jan 23:</strong> Week closes at Rs.801.30, down 4.29% on profit booking</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-va..."
      }
    ],
    "total": 183,
    "sid": "10039497",
    "stock_news_url": "https://www.marketsmojo.com/news/senores-pharmaceuticals-10039497"
  },
  "announcements": [
    {
      "caption": "Intimation Regarding Changes In The Senior Management Personnel (SMP) Of The Company",
      "datetime": "17-Mar-2026",
      "details": "Senores Pharmaceuticals Limited has informed the Exchange regarding change in the senior management personnel (SMP) of the Company.",
      "source": "BSE"
    },
    {
      "caption": "Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.",
      "datetime": "12-Mar-2026",
      "details": "The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on March 12 2026 for Renosen Pharmaceuticals Pvt Ltd",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "09-Mar-2026",
      "details": "Senores Pharmaceuticals Limited has informed the Exchange regarding Analyst/Institutional Investor meet scheduled to be held on March 12 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Senores Pharmaceuticals Ltd Surges 7.65% to Day's High of Rs 787.15 — Outperforms Sector by 6 Percentage Points

2026-03-25 10:21:36

The Sensex climbed 1.67% on 25 Mar 2026, yet Senores Pharmaceuticals Ltd outpaced the broader market with a 7.65% gain, reaching an intraday high of Rs 787.15. This 6-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a market-wide lift.

Read full news article

Senores Pharmaceuticals Ltd is Rated Hold

2026-03-18 10:10:03

Senores Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 06 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and overall market standing.

Read full news article

Senores Pharmaceuticals Ltd Technical Momentum Shifts Signal Stabilisation Amid Mixed Indicators

2026-03-17 08:04:37

Senores Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of technical indicators. Despite recent price gains, the stock’s mixed signals across MACD, RSI, moving averages, and volume-based metrics suggest cautious optimism for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

Senores Pharmaceuticals Ltd is Rated Hold

2026-03-07 10:10:27

Senores Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 06 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 March 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Senores Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicators

2026-03-04 08:08:18

Senores Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bearish stance. Despite a modest daily price decline, the stock’s technical indicators present a complex picture, with some signals suggesting caution while others hint at potential resilience in the near term.

Read full news article

Senores Pharmaceuticals Ltd is Rated Hold

2026-02-24 10:10:04

Senores Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 06 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Senores Pharmaceuticals Ltd is Rated Hold

2026-02-12 10:10:03

Senores Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 06 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 12 February 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Senores Pharmaceuticals Ltd is Rated Hold

2026-02-01 10:10:04

Senores Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 06 November 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 01 February 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Senores Pharmaceuticals Gains 1.40%: 4 Key Factors Driving the Week’s Moves

2026-01-24 09:00:07

Key Events This Week

Jan 19: Stock opens strong at Rs.806.55 (+2.06%) despite Sensex decline

Jan 20: Q3 FY26 results reveal robust growth but stock dips 2.90%

Jan 21: Intraday high of Rs.838.60 with 7.13% surge on strong financial trend

Jan 22: Quality grade upgraded amid strong fundamentals

Jan 23: Week closes at Rs.801.30, down 4.29% on profit booking

Week Open

Read full news article

View All News